Yolife
Nightingale Health is building sustainable healthcare by developing the world's most advanced health check, which provides risk detection for multiple chronic diseases from a single blood sample. Their technology can be scaled to entire populations at a low cost and aims to replace current routine risk assessments. By detecting disease risks on a population level, Nightingale Health enables effective targeting and tracking of health interventions and better prevention of chronic diseases. The company operates globally with a parent company in Finland and subsidiaries in Japan, the United States, Singapore, and the United Kingdom, serving customers in over 25 countries across the healthcare and medical research sectors. Their technology is utilized in major health initiatives like the UK Biobank and is validated by over 600 peer-reviewed publications. Nightingale Health aims to reduce health inequalities and make preventative healthcare accessible to everyone.
Yolife
Nightingale Health is building sustainable healthcare by developing the world's most advanced health check, which provides risk detection for multiple chronic diseases from a single blood sample. Their technology can be scaled to entire populations at a low cost and aims to replace current routine risk assessments. By detecting disease risks on a population level, Nightingale Health enables effective targeting and tracking of health interventions and better prevention of chronic diseases. The company operates globally with a parent company in Finland and subsidiaries in Japan, the United States, Singapore, and the United Kingdom, serving customers in over 25 countries across the healthcare and medical research sectors. Their technology is utilized in major health initiatives like the UK Biobank and is validated by over 600 peer-reviewed publications. Nightingale Health aims to reduce health inequalities and make preventative healthcare accessible to everyone.
TL;DR
Company: Yolife (Yolife GmbH)
Headquarters: Berlin, Germany
Founded: 2017
Product: B2C mobile app for personalized lifestyle coaching focused on longevity
Exit / acquisition: Acquired by Nightingale Health (July 2021, acqui-hire reported)
Company Overview
Problem Domain
Preventive health, longevity, behavior change
Founded
2017
Industry
Digital health / Longevity
Funding Track Record
Seed round reported September 2020; last financing vehicle reported as a Convertible Note.
Pre-seed investment recorded November 2019.
884000.00
Reported acquisition by Nightingale Health for approximately €740k (~$884k).
Investor Signal
“Early investors include Longevitytech.fund, APX, and Hypergrowth Ventures”